Emanuel Subo, Field Benjamin Ct, Joy Mark, Fan Xuejuan, Williams John, Kaba Riyaz A, Lip Gregory Y H, de Lusignan Simon
Department of Clinical and Experimental Medicine, University of Surrey Stag Hill Campus, Guildford, UK
Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.
Open Heart. 2025 May 21;12(1):e002923. doi: 10.1136/openhrt-2024-002923.
In England, most prescribing of direct-acting oral anticoagulants (DOACs) for patients with chronic kidney disease (CKD) and atrial fibrillation (AF) takes place in primary care. The 2024 European Society of Cardiology guidelines introduced the AF-CARE ((C) comorbidities and risk factors; (A) avoid stroke and thromboembolism by appropriate prescription of oral anticoagulants; (R) rate and rhythm control; (E) evaluation and reassessment should be individualised for every patient, with a dynamic approach) framework to address this.
To describe any health disparities in CKD and AF, including anticoagulation management and correct dosing of DOACs.
Using English primary care sentinel network data from 2018 to 2022, demographics of AF and CKD including anticoagulation and appropriate DOAC dosing according to creatinine clearance and other factors were assessed. The study also examined disparities in CKD and AF in relation to socioeconomic status and ethnicity. We defined socioeconomic status by Index of Multiple Deprivation (IMD), a weighted composite index combining information from the domains of deprivation including income.
Of 10 513 950 people registered with general practices in the sentinel network, 2.9% (n=304 678) were aged ≥18 years with a diagnosis of AF. The prevalence of CKD in AF was 26.0% (n=79 210) and 63.3% of people eligible for anticoagulation were prescribed a DOAC. Among the 54 897 people with AF and CKD 3 or 4, greater likelihood of DOAC prescribing was associated with higher socioeconomic status. Socioeconomic disparities in anticoagulation increased through the 5 years. No association was identified between ethnicity and likelihood of being anticoagulated.In terms of correct dosing, there was no association with socioeconomic status. Overdosing was more frequent than underdosing. Incorrect dosing was associated with male sex (OR 0.80 (95% CI 0.74, 0.86)), dementia (OR 0.94 (0.83, 1.07)) and frailty (OR 0.42 (0.37, 0.48)).
People in the most deprived IMD quintile were least likely to be anticoagulated. Incorrect DOAC dosing was associated with male sex, increasing frailty and dementia. Socioeconomic and health disparities are apparent in anticoagulation prescribing and should be addressed in line with the AF-CARE framework.
在英国,针对慢性肾脏病(CKD)合并心房颤动(AF)患者开具直接口服抗凝剂(DOACs)的处方大多在基层医疗中进行。2024年欧洲心脏病学会指南引入了AF-CARE((C)合并症和危险因素;(A)通过适当开具口服抗凝剂避免中风和血栓栓塞;(R)心率和节律控制;(E)评估和重新评估应针对每位患者进行个体化,并采用动态方法)框架来解决这一问题。
描述CKD和AF患者中的任何健康差异,包括抗凝管理和DOACs的正确剂量。
利用2018年至2022年英国基层医疗哨点网络数据,评估AF和CKD的人口统计学特征,包括抗凝情况以及根据肌酐清除率和其他因素确定的DOACs正确剂量。该研究还考察了CKD和AF在社会经济地位和种族方面的差异。我们通过多重剥夺指数(IMD)来定义社会经济地位,这是一个综合加权指数,结合了包括收入在内的剥夺领域信息。
在哨点网络中注册全科医疗服务的10513950人中,2.9%(n = 3046